214 related articles for article (PubMed ID: 9434752)
1. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
[TBL] [Abstract][Full Text] [Related]
2. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.
Chow T; Imaoka S; Hiroi T; Funae Y
Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501
[TBL] [Abstract][Full Text] [Related]
3. Catalytic specificity of CYP2D isoforms in rat and human.
Hiroi T; Chow T; Imaoka S; Funae Y
Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
[TBL] [Abstract][Full Text] [Related]
4. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.
Bromek E; Haduch A; Daniel WA
Eur J Pharmacol; 2010 Jan; 626(2-3):171-8. PubMed ID: 19818757
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the n-alkane and fatty acid hydroxylating cytochrome P450 forms 52A3 and 52A4.
Scheller U; Zimmer T; Kärgel E; Schunck WH
Arch Biochem Biophys; 1996 Apr; 328(2):245-54. PubMed ID: 8645001
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
8. Expression and characterization of canine cytochrome P450 2D15.
Roussel F; Duignan DB; Lawton MP; Obach RS; Strick CA; Tweedie DJ
Arch Biochem Biophys; 1998 Sep; 357(1):27-36. PubMed ID: 9721180
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
[TBL] [Abstract][Full Text] [Related]
10. Importance of CYP2D3 in polymorphism of diazepam p-hydroxylation in rats.
Sakai N; Saito K; Kim HS; Kazusaka A; Ishizuka M; Funae Y; Fujita S
Drug Metab Dispos; 2005 Nov; 33(11):1657-60. PubMed ID: 16081673
[TBL] [Abstract][Full Text] [Related]
11. Characterization of two P-450 isozymes placed in the rat CYP2D subfamily.
Ohishi N; Imaoka S; Suzuki T; Funae Y
Biochim Biophys Acta; 1993 Nov; 1158(3):227-36. PubMed ID: 8251521
[TBL] [Abstract][Full Text] [Related]
12. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.
McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS
Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831
[TBL] [Abstract][Full Text] [Related]
13. Complementary DNA cloning and characterization of cytochrome P450 2D29 from Japanese monkey liver.
Hichiya H; Takemi C; Tsuzuki D; Yamamoto S; Asaoka K; Suzuki S; Satoh T; Shinoda S; Kataoka H; Narimatsu S
Biochem Pharmacol; 2002 Oct; 64(7):1101-10. PubMed ID: 12234613
[TBL] [Abstract][Full Text] [Related]
14. The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6.
Fukuda T; Nishida Y; Imaoka S; Hiroi T; Naohara M; Funae Y; Azuma J
Arch Biochem Biophys; 2000 Aug; 380(2):303-8. PubMed ID: 10933885
[TBL] [Abstract][Full Text] [Related]
15. Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation.
Gut J; Gasser R; Dayer P; Kronbach T; Catin T; Meyer UA
FEBS Lett; 1984 Aug; 173(2):287-90. PubMed ID: 6146537
[TBL] [Abstract][Full Text] [Related]
16. Complementary DNA cloning, functional expression and characterization of a novel cytochrome P450, CYP2D50, from equine liver.
DiMaio Knych HK; Stanley SD
Biochem Pharmacol; 2008 Oct; 76(7):904-11. PubMed ID: 18692486
[TBL] [Abstract][Full Text] [Related]
17. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
18. The roles of amino acid residues at positions 43 and 45 in microsomal contents and enzymatic functions of rat CYP2D1 and CYP2D2.
Narimatsu S; Imoto K; Isobe T; Kiryu K; Naito S; Hichiya H; Funae Y; Hanioka N; Yamamoto S
Biochem Biophys Res Commun; 2004 Nov; 324(2):627-33. PubMed ID: 15474473
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic properties of cytochrome P450 catalyzing 3'-hydroxylation of naringenin from the white-rot fungus Phanerochaete chrysosporium.
Kasai N; Ikushiro S; Hirosue S; Arisawa A; Ichinose H; Wariishi H; Ohta M; Sakaki T
Biochem Biophys Res Commun; 2009 Sep; 387(1):103-8. PubMed ID: 19576179
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
